BioCentury
ARTICLE | Company News

ChromaVision licenses Micromet antibody

July 24, 2000 7:00 AM UTC

Micromet (Munich, Germany) granted CVSN a global license to manufacture, market and distribute the A45-B/B3 antibody, for use in diagnostic tests to detect tumor cells. ...